The prognostic and immune significance of SLAMF9 in pan-cancer and validation of its role in colorectal cancer.
Ontology highlight
ABSTRACT: SLAMF9, a member of the conserved lymphocyte activation molecules family (SLAMF), has been less investigated compared to other SLAMs, especially concerning its implications across various cancer types. In our systematic pan-cancer investigation, we observed elevated SLAMF9 expression in various tumor tissues, which was correlated with reduced patient survival across most malignancies. Correlation analyses further revealed significant associations between SLAMF9 expression and immune cell infiltrates, immune checkpoint inhibitors, tumor mutation load, microsatellite instability, and epithelial-mesenchymal transition (EMT) scores. Cell-based assays demonstrated that SLAMF9 knockdown attenuated the proliferative, motile, and invasive capacities of colorectal cancer (CRC) cells. In a nude mous
SUBMITTER: Zhao C
PROVIDER: S-EPMC11297030 | biostudies-literature | 2024 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA